2023 universal registration document

2. Corporate governance

2.6 Summary statement of trading by Directors and corporate officers in L’Oréal shares in 2023

AFEP-MEDEF Code recommendations	L’Oréal’s practices and justifications
	L’Oréal’s practices and justifications As such, in respect of the employment contract, pursuant to the provisions of the National Collective Bargaining Agreement for the Chemical Industries and in the event of termination of the employment contract, the indemnity due in consideration of the non-compete clause would be payable monthly for two years on the basis of two-thirds of the monthly fixed remuneration attached to the suspended employment contract unless Mr Hieronimus were to be released from application of the clause. This clause is not applicable in the event of voluntary retirement or retirement at the Company’s request, meaning that no non-compete indemnity would be paid in this situation.

AFEP-MEDEF Code recommendations

L’Oréal’s practices and justifications

As such, in respect of the employment contract, pursuant to the provisions of the National Collective Bargaining Agreement for the Chemical Industries and in the event of termination of the employment contract, the indemnity due in consideration of the non-compete clause would be payable monthly for two years on the basis of two-thirds of the monthly fixed remuneration attached to the suspended employment contract unless Mr Hieronimus were to be released from application of the clause. This clause is not applicable in the event of voluntary retirement or retirement at the Company’s request, meaning that no non-compete indemnity would be paid in this situation.

2.6. Summary statement of trading by Directors and corporate officers in L’Oréal shares in 2023

(Article 223-26 of the General Regulation of the French Financial Markets Authority (AMF))

Person concerned	Description of the financial instrument	Nature of transaction	Number of transactions	Total amount
Mr Jean-Paul Agon Chairman of the Board of Directors	Mr Jean-Paul Agon Chairman of the Board of Directors Description of the financial instrument Shares	Mr Jean-Paul Agon Chairman of the Board of Directors Nature of transaction Final vesting of free shares granted subject to performance conditions (ACAs)* Delivery in April 2023 of the ACAs Plan of 18 April 2019 (see subsections 2.4.4. and 2.4.5.).	Mr Jean-Paul Agon Chairman of the Board of Directors Number of transactions 1	Mr Jean-Paul Agon Chairman of the Board of Directors Total amount €0
Mr Jean-Paul Agon Chairman of the Board of Directors	Person concerned Shares	Description of the financial instrument Sale	Nature of transaction 5	Number of transactions €17,229,062.71
Mr Nicolas Hieronimus Chief Executive Officer Director	Mr Nicolas Hieronimus Chief Executive Officer Director Description of the financial instrument Shares	Mr Nicolas Hieronimus Chief Executive Officer Director Nature of transaction Final vesting of free shares granted subject to performance conditions (ACAs)	Mr Nicolas Hieronimus Chief Executive Officer Director Number of transactions 1	Mr Nicolas Hieronimus Chief Executive Officer Director Total amount €0
Mr Nicolas Hieronimus Chief Executive Officer Director	Person concerned Shares	Description of the financial instrument Sale	Nature of transaction 1	Number of transactions €2,328,090
Mr Paul Bulcke Director	Mr Paul Bulcke Director Description of the financial instrument Shares	Mr Paul Bulcke Director Nature of transaction Sale	Mr Paul Bulcke Director Number of transactions 1	Mr Paul Bulcke Director Total amount €901,700
Ms Françoise Bettencourt Meyers Director	Ms Françoise Bettencourt Meyers Director Description of the financial instrument Shares	Ms Françoise Bettencourt Meyers Director Nature of transaction Contribution in kind (contributor)On 29 December 2023, Ms Françoise Bettencourt Meyers made a contribution in kind of 27,650,000 L’Oréal shares to the company Financière L’Arcouest S. A.S. (see AMF decision no. 223C2036 of 12 December 2023), with a contribution value of €405.40 per L’Oréal share contributed.	Ms Françoise Bettencourt Meyers Director Number of transactions 1	Ms Françoise Bettencourt Meyers Director Total amount 27,650,000 shares Unit price: €405.40
Company (Financière L’Arcouest S.A.S.) related to Ms Françoise Bettencourt Meyers (Director)	Company (Financière L’Arcouest S.A.S.) related to Ms Françoise Bettencourt Meyers (Director) Description of the financial instrument Shares	Company (Financière L’Arcouest S.A.S.) related to Ms Françoise Bettencourt Meyers (Director) Nature of transaction Contribution in kind (beneficiary)On 29 December 2023, Ms Françoise Bettencourt Meyers made a contribution in kind of 27,650,000 L’Oréal shares to the company Financière L’Arcouest S. A.S. (see AMF decision no. 223C2036 of 12 December 2023), with a contribution value of €405.40 per L’Oréal share contributed.	Company (Financière L’Arcouest S.A.S.) related to Ms Françoise Bettencourt Meyers (Director) Number of transactions 1	Company (Financière L’Arcouest S.A.S.) related to Ms Françoise Bettencourt Meyers (Director) Total amount 27,650,000 shares Unit price: €405.40

* Delivery in April 2023 of the ACAs Plan of 18 April 2019 (see subsections 2.4.4. and 2.4.5.).

** On 29 December 2023, Ms Françoise Bettencourt Meyers made a contribution in kind of 27,650,000 L’Oréal shares to the company Financière L’Arcouest S. A.S. (see AMF decision no. 223C2036 of 12 December 2023), with a contribution value of €405.40 per L’Oréal share contributed.